Pfizer's 2021 profits doubled to $22 bn on strong Covid vaccine sales
PremiumPfizer also expects $22 billion in sales of Paxlovid, the company's pill for Covid-19, in 2022
Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to $22 billion.